HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kevin Gunn Selected Research

vixotrigine

9/2020Discovery of Vixotrigine: A Novel Use-Dependent Sodium Channel Blocker for the Treatment of Trigeminal Neuralgia.
4/2017Safety and efficacy of a Nav1.7 selective sodium channel blocker in patients with trigeminal neuralgia: a double-blind, placebo-controlled, randomised withdrawal phase 2a trial.
11/2013Novel design for a phase IIa placebo-controlled, double-blind randomized withdrawal study to evaluate the safety and efficacy of CNV1014802 in patients with trigeminal neuralgia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kevin Gunn Research Topics

Disease

3Trigeminal Neuralgia (Tic Douloureux)
09/2020 - 11/2013
2Pain (Aches)
09/2020 - 11/2013
1Cardiac Arrhythmias (Arrythmia)
09/2020
1Epilepsy (Aura)
09/2020
1Neuralgia (Stump Neuralgia)
09/2020
1Headache (Headaches)
04/2017
1Sleep Wake Disorders
04/2017
1Tremor (Tremors)
04/2017
1Fever (Fevers)
04/2017
1Vomiting
04/2017
1Dizziness (Lightheadedness)
04/2017
1Nasopharyngitis
04/2017

Drug/Important Bio-Agent (IBA)

3Sodium Channel BlockersIBA
09/2020 - 11/2013
3vixotrigineIBA
09/2020 - 11/2013
2Oxcarbazepine (Trileptal)FDA LinkGeneric
04/2017 - 11/2013
2Carbamazepine (Tegretol)FDA LinkGeneric
04/2017 - 11/2013
1Voltage-Gated Sodium Channel BlockersIBA
09/2020
1Anesthetics (Anesthetic Agents)IBA
09/2020
1Pharmaceutical PreparationsIBA
09/2020
1Voltage-Gated Sodium ChannelsIBA
09/2020

Therapy/Procedure

1Activities of Daily Living (ADL)
11/2013